Innoviva (INVA) Assets (2010 - 2026)
Innoviva posted quarterly Assets of $1.8 billion for Q1 2026, up 46.41% year-on-year from $1.3 billion in Q1 2025, and up 12.32% on a QoQ basis from $1.6 billion in Q4 2025.
Innoviva (INVA) has 17 years of Assets data on file, last reported at $1.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 46.41% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 46.41% YoY), and the FY2025 full-year result was $1.6 billion, up 25.68% from the prior year.
- Assets for Q1 2026 stood at $1.8 billion, up from $1.6 billion in the prior quarter.
- Across five years, Assets topped out at $1.8 billion in Q1 2026 and bottomed at $1.1 billion in Q1 2022.
- The 5-year median for Assets is $1.2 billion (2023), against an average of $1.3 billion.
- The widest annual swing landed in 2022, when Assets soared 49.65%; it then declined 10.51% in 2023.
- A 5-year view of Assets shows it stood at $1.2 billion in 2022, then rose by 0.98% to $1.2 billion in 2023, then rose by 4.63% to $1.3 billion in 2024, then grew by 25.68% to $1.6 billion in 2025, then gained by 12.32% to $1.8 billion in 2026.
- The last three Assets figures came in at $1.8 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.84 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 926.40 Mn |
| Sep 30, 2021 | 887.24 Mn |
| Jun 30, 2021 | 789.15 Mn |
| Mar 31, 2021 | 1.09 Bn |
| Dec 31, 2020 | 999.57 Mn |
| Sep 30, 2020 | 922.26 Mn |
| Jun 30, 2020 | 879.62 Mn |
| Mar 31, 2020 | 788.01 Mn |
| Dec 31, 2019 | 724.83 Mn |
| Sep 30, 2019 | 675.95 Mn |
| Jun 30, 2019 | 642.31 Mn |
| Mar 31, 2019 | 590.11 Mn |
| Dec 31, 2018 | 548.19 Mn |
| Sep 30, 2018 | 277.69 Mn |
| Jun 30, 2018 | 338.69 Mn |
| Mar 31, 2018 | 276.75 Mn |
| Dec 31, 2017 | 367.34 Mn |
| Sep 30, 2017 | 390.97 Mn |
| Jun 30, 2017 | 372.02 Mn |
| Mar 31, 2017 | 391.87 Mn |
| Dec 31, 2016 | 379.00 Mn |
| Sep 30, 2016 | 370.54 Mn |
| Jun 30, 2016 | 378.11 Mn |
| Mar 31, 2016 | 387.83 Mn |
| Dec 31, 2015 | 408.93 Mn |
| Sep 30, 2015 | 437.63 Mn |
| Jun 30, 2015 | 462.09 Mn |
| Mar 31, 2015 | 488.70 Mn |
| Dec 31, 2014 | 521.65 Mn |
| Sep 30, 2014 | 553.71 Mn |
| Jun 30, 2014 | 605.61 Mn |
| Mar 31, 2014 | 605.03 Mn |
| Dec 31, 2013 | 681.26 Mn |
| Sep 30, 2013 | 666.02 Mn |
| Jun 30, 2013 | 594.70 Mn |
| Mar 31, 2013 | 591.52 Mn |
| Dec 31, 2012 | 368.58 Mn |
| Sep 30, 2012 | 383.94 Mn |
| Jun 30, 2012 | 399.42 Mn |
| Mar 31, 2012 | 217.73 Mn |
| Dec 31, 2011 | 258.78 Mn |
| Sep 30, 2011 | 283.33 Mn |
| Jun 30, 2011 | 303.12 Mn |
| Dec 31, 2010 | 331.20 Mn |